Key Research Effects & Mechanisms

• Synergistic Dual Incretin Activation: Unlike single-receptor agonists, GLP-2 concurrently binds to and activates both GIP and GLP-1 receptors. In vitro and in vivo models show that this dual agonism produces a profound, synergistic effect on pancreatic beta-cell activity, enhancing insulin expression while concurrently regulating glucagon secretion.

• Advanced Glucoregulatory Homeostasis: In research models evaluating insulin resistance, GLP-2 exposure significantly stabilizes blood glucose profiles during tolerance testing. It aids investigators in studying the physiological mechanisms that lower hepatic glucose output and enhance peripheral tissue insulin sensitivity.

• Central Appetite Signaling & Satiety Modulation: Studies focused on neuro-metabolic pathways indicate that GLP-2 successfully interacts with central nervous system receptors responsible for appetite regulation. Researchers utilize it to observe profound delays in gastric emptying rates and the upregulation of structural satiety markers.

• Ectopic Fat and Adipose Tissue Breakdown: Beyond systemic weight homeostasis, GLP-2 is actively evaluated for its impact on lipid profiles. Research tracks its capacity to mobilize stored triglycerides and decrease ectopic fat accumulation, particularly within hepatic and visceral tissue zones.

Disclaimer: This product is for research purposes only. It is not intended for direct human consumption.